Jul 08, 2019
Copiktra (Duvelisib; Verastem/Yakult Honsha) Drug Overview & Product Profiles 2017-2026
Mar 06, 2019
Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA(TM) for $30 Million Gross Proceeds
Feb 06, 2019
Biotechnology Companies See Growth in Optic Treatment Sectors
Nov 05, 2018
Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results
Oct 16, 2018
Catalent and Verastem Oncology Partner on Newly Launched, FDA Approved COPIKTRA(TM) (duvelisib) Capsules
Oct 04, 2018
Study Shows Duvelisib Has Marked Response, Survival Benefit in Difficult-to-Treat Leukemia and Lymphoma Compared with Standard Therapy
Oct 01, 2018
Infinity Pharmaceuticals Earns $22 Million Payment From Verastem Oncology For FDA Approval Of COPIKTRA(TM) (duvelisib) And Updates 2018 Financial Guidance
Aug 30, 2018
MEI Pharma Reports Fiscal Year 2018 Results and Operational Highlights
Aug 13, 2018
Chronic Lymphocytic Leukemia (CLL) Market Insights, Epidemiology and Market Forecast to 2027
Aug 07, 2018
Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results
Jun 22, 2018
Biotech's Making Great Progress
May 08, 2018
Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results
Mar 15, 2018
Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Jan 08, 2018
Infinity Provides Update on IPI-549 Phase 1/1b Study, 2018 Goals and Financial Guidance
Nov 07, 2017
Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results
Aug 03, 2017
Infinity Provides Company Update and Reports Second Quarter 2017 Financial Results